Biochemical aspects of muscle differentiation as analyzed by in vitro cultivation techniques. 1979

F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput

Myoblasts cultivated in vitro will undergo terminal differentiation to form muscle fibres. Teratoma derived mouse cell lines, a pluripotent primitive line, and a muscle cell line, provide a possibility for comparing RNA populations in an early precursor cell with those in committed myoblasts and differentiated myotubes. Molecular hybridization analyses led to the conclusion that new RNA sequences appear in the cytoplasm during muscle differentiation. Such muscle specific sequences are not detectable in the nuclear RNA of myoblasts or primitive cells. Studies of protein synthesis during terminal myogenesis indicate co-ordinate expression of the muscle contractile proteins. These represent distinct isozymes, distinguishable from the contractile proteins of other cell types. In the case of myosin light chains isozymic transitions between different muscle forms have been identified during early development.

UI MeSH Term Description Entries
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003285 Contractile Proteins Proteins which participate in contractile processes. They include MUSCLE PROTEINS as well as those found in other cells and tissues. In the latter, these proteins participate in localized contractile events in the cytoplasm, in motile activity, and in cell aggregation phenomena. Contractile Protein,Protein, Contractile,Proteins, Contractile
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA
D013724 Teratoma A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642) Dysembryoma,Teratoid Tumor,Teratoma, Cystic,Teratoma, Mature,Teratoma, Benign,Teratoma, Immature,Teratoma, Malignant,Benign Teratoma,Benign Teratomas,Dysembryomas,Immature Teratoma,Immature Teratomas,Malignant Teratoma,Malignant Teratomas,Teratoid Tumors,Teratomas,Teratomas, Benign,Teratomas, Immature,Teratomas, Malignant,Tumor, Teratoid,Tumors, Teratoid

Related Publications

F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
May 1978, The Biochemical journal,
F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
January 1990, Comparative biochemistry and physiology. B, Comparative biochemistry,
F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
January 1969, Current topics in developmental biology,
F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
January 1964, Clinical pharmacology and therapeutics,
F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
May 1976, Journal of gerontology,
F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
January 1973, Advances in morphogenesis,
F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
January 1971, Advances in clinical chemistry,
F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
April 1953, Bollettino della Societa italiana di biologia sperimentale,
F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
October 1983, Cancer research,
F Gros, and N Affara, and M E Buckingham, and M Jacquet, and R G Whalen, and P Daubas, and J C Lelong, and D Caput
January 2002, Advances in biochemical engineering/biotechnology,
Copied contents to your clipboard!